Vida Ventures
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
10Deep-tech portfolio3 active
7Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Candid Therapeutics
16Co-investorsShare a portfolio company
Portfolio · 10 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Contineum Therapeutics | Biotech | Active | — | — |
| Poplar Therapeutics | Biotech | Active | — | — |
| Structure Therapeutics | Biotech | Active | — | — |
| Candid Therapeutics | Biotech | Acquired | Sep 13, 2024 | $206.2M |
| Halda Therapeutics | Biotech | Acquired | Aug 12, 2024 | $197.9M |
| Scorpion Therapeutics | Biotech | Acquired | Jul 16, 2024 | $297.4M |
| Kyverna Therapeutics | Biotech | Public | Nov 7, 2023 | $152.0M |
| Neogene Therapeutics | Biotech | Acquired | Sep 14, 2020 | $125.0M |
| Allogene Therapeutics | Biotech | Public | Apr 19, 2018 | $411.8M |
| Attovia Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#48
Portfolio exits#26
Raises, 12 months#88
Co-investors#128
Co-investors
- RA CapitalVenture capital3 shared
- OrbiMedVenture capital2 shared
- Boxer CapitalVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Deep Track CapitalVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- Goldman Sachs AlternativesVenture capital1 shared
- Mirae Asset Capital Life ScienceVenture capital1 shared
- Pivotal bioVenture PartnersVenture capital1 shared
Sectors
- Biotech10
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.